Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Encompass Health (EHC) stocks

Learn how to easily invest in Encompass Health stocks.

Encompass Health is a medical care facilities business based in the US. Encompass Health stocks (EHC.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $79.76 – a decrease of 3.68% over the previous week. Encompass Health employs 34,000 staff and has a trailing 12-month revenue of around $5.3 billion.

How to buy stocks in Encompass Health

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EHC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Encompass Health stock price (NYSE:EHC)

Use our graph to track the performance of EHC stocks over time.

Encompass Health shares at a glance

Information last updated 2022-09-26.
Latest market close$45.23
52-week range$41.92 - $60.68
50-day moving average $50.77
200-day moving average $51.26
Wall St. target price$65.33
PE ratio 14.5933
Dividend yield $1.12 (1.26%)
Earnings per share (TTM) $3.27

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95–$6.95
$0 if conditions met, else $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
min $1.00, max 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
FREE TRADES
Wealthsimple
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get $25 when you open a Wealthsimple account and fund at least $150.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends October 31, 2022.
loading

Compare up to 4 providers

Is it a good time to buy Encompass Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Encompass Health price performance over time

Historical closes compared with the close of $45.23 from 2022-09-30

1 week (2022-09-26) -3.68%
1 month (2022-09-02) -6.55%
3 months (2022-07-01) -2.81%
6 months (2022-03-30) N/A
1 year (2021-10-01) -38.78%
2 years (2020-10-02) -30.89%
3 years (2019-10-03) 62.06
5 years (2017-10-03) 46

Is Encompass Health under- or over-valued?

Valuing Encompass Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Encompass Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Encompass Health's P/E ratio

Encompass Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Encompass Health shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Encompass Health's EBITDA

Encompass Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $991.5 million.

The EBITDA is a measure of a Encompass Health's overall financial performance and is widely used to measure a its profitability.

Encompass Health financials

Revenue TTM $5.3 billion
Operating margin TTM 13.78%
Gross profit TTM $2 billion
Return on assets TTM 6.63%
Return on equity TTM 17.83%
Profit margin 6.22%
Book value $20.07
Market capitalisation $4.8 billion

TTM: trailing 12 months

Encompass Health share dividends

25%

Dividend payout ratio: 24.55% of net profits

Recently Encompass Health has paid out, on average, around 24.55% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.26% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Encompass Health shareholders could enjoy a 1.26% return on their shares, in the form of dividend payments. In Encompass Health's case, that would currently equate to about $1.12 per share.

While Encompass Health's payout ratio might seem low, this can signify that Encompass Health is investing more in its future growth.

Encompass Health's most recent dividend payout was on 17 October 2022. The latest dividend was paid out to all shareholders who bought their shares by 30 September 2022 (the "ex-dividend date").

Have Encompass Health's shares ever split?

Encompass Health's shares were split on a 1257:1000 basis on 1 July 2022. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1257 shares. This wouldn't directly have changed the overall worth of your Encompass Health shares – just the quantity. However, indirectly, the new 20.4% lower share price could have impacted the market appetite for Encompass Health shares which in turn could have impacted Encompass Health's share price.

Encompass Health share price volatility

Over the last 12 months, Encompass Health's shares have ranged in value from as little as $41.9236 up to $60.6792. A popular way to gauge a stock's volatility is its "beta".

EHC.US volatility(beta: 0.91)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Encompass Health's is 0.9113. This would suggest that Encompass Health's shares are less volatile than average (for this exchange).

Encompass Health overview

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site